Abdul Khader

Abdul Khader

Active Director Director DIN 07285495
DIN 07285495 First appointment Sep 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2015
Shareholding value •••• Premium profile

About Abdul Khader

Data last updated:

Abdul Khader is a Director at Kasturba Pharmaceuticals Private Limited (since 2015). The company operates in Chemicals. Kasturba Pharmaceuticals Private Limited reported revenue of ₹1 Lakh (FY 2024).

DIN 07285495
Primary Designation Director
Industry Chemicals
First Appointment 10 Sep 2015
Oldest Company Age 11 yrs
Largest company Kasturba Pharmaceuticals Private Limited · ₹1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Sep 20152015₹1 Lakh (FY 2024)Active

Board colleagues of Abdul Khader

Directorship timeline

Open interactive timeline →
Kasturba Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abdul Khader

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Khader

Abdul Khader currently holds 1 directorship: Kasturba Pharmaceuticals Private Limited (Director, since 10 Sep 2015, revenue ₹1 Lakh (FY 2024)).

Abdul Khader was first appointed on 10 Sep 2015 as Director at Kasturba Pharmaceuticals Private Limited.

The current boards of Abdul Khader's companies include Ershad Shafi Ahmed (Kasturba Pharmaceuticals Private Limited), Hasina Ahmed (Kasturba Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available